Health and FitnessHealth and Fitness
Wed, January 18, 2012
[ Wed, Jan 18th 2012 ] - Market Wire
Elster Group mit neuem CFO
[ Wed, Jan 18th 2012 ] - Market Wire
Elster Announces CFO Transition
Tue, January 17, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
SPY(R) Joins USA Cycling

Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2012 Earnings Release Date and Teleconference


Published on 2012-01-17 12:25:47 - Market Wire
  Print publication without navigation


Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2012 Earnings Release... -- EXTON, Pa., Jan. 17, 2012 /PRNewswire/ --

Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2012 Earnings Release Date and Teleconference

[ ]

EXTON, Pa., Jan. 17, 2012 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: [ KNSY ]) today announced that it will release its earnings results for its second quarter ended December 31, 2011 at 7:00 A.M. Eastern Time on Thursday, February 2, 2012. 

Joe Kaufmann, President and CEO, will be hosting a teleconference discussing the earnings results on Thursday, February 2, 2012 at 9:00 A.M. Eastern Time

To participate in the teleconference call, please dial 703-639-1429.  Individuals interested in listening to the teleconference may also do so over the Internet at [ www.kenseynash.com ].  To do so, please go to [ www.kenseynash.com ] and choose the Investor Relations page.  Please allow 15 minutes prior to the start of the call to register and download and/or install any necessary software.  A replay of the teleconference will be archived at [ www.kenseynash.com ] and may be accessed following the teleconference.  The teleconference call will also be available for replay starting Thursday, February 2, 2012 at 11:00 A.M. Eastern Time through Thursday, February 9, 2012 at 11:59 P.M. Eastern Time by dialing 1-800-475-6701 with an access code of 233975.

About Kensey Nash Corporation.  Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit [ www.kenseynash.com ].

 

 

SOURCE Kensey Nash Corporation

[ Back to top ]

RELATED LINKS
[ http://www.kenseynash.com ]